HEADER TRANSFERASE 24-APR-23 8OUU TITLE CRYSTAL STRUCTURE OF D1228V C-MET BOUND BY COMPOUND 29 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPATOCYTE GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: HGF RECEPTOR,HGF/SF RECEPTOR,PROTO-ONCOGENE C-MET,SCATTER COMPND 5 FACTOR RECEPTOR,SF RECEPTOR,TYROSINE-PROTEIN KINASE MET; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MET; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS KINASE, INHIBITOR, CANCER RESEARCH, DRUG DISCOVERY, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR G.W.COLLIE REVDAT 2 26-JUL-23 8OUU 1 JRNL REVDAT 1 05-JUL-23 8OUU 0 JRNL AUTH I.N.MICHAELIDES,G.W.COLLIE,U.BORJESSON,C.VASALOU,O.ALKHATIB, JRNL AUTH 2 L.BARLIND,T.CHEUNG,I.L.DALE,K.J.EMBREY,E.J.HENNESSY, JRNL AUTH 3 P.KHURANA,C.M.KOH,M.L.LAMB,J.LIU,T.A.MOSS,D.J.O'NEILL, JRNL AUTH 4 C.PHILLIPS,J.SHAW,A.SNIJDER,R.I.STORER,C.J.STUBBS,F.HAN, JRNL AUTH 5 C.LI,J.QIAO,D.Q.SUN,J.WANG,P.WANG,W.YANG JRNL TITL DISCOVERY AND OPTIMIZATION OF THE FIRST ATP COMPETITIVE JRNL TITL 2 TYPE-III C-MET INHIBITOR. JRNL REF J.MED.CHEM. V. 66 8782 2023 JRNL REFN ISSN 0022-2623 JRNL PMID 37343272 JRNL DOI 10.1021/ACS.JMEDCHEM.3C00401 REMARK 2 REMARK 2 RESOLUTION. 1.77 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.8 (8-JUN-2022) REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.77 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 54.86 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 64804 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.203 REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.225 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 3122 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.77 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.78 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.21 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3060 REMARK 3 BIN FREE R VALUE : 0.4306 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 63 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4520 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 83 REMARK 3 SOLVENT ATOMS : 431 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.47 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 12.44550 REMARK 3 B22 (A**2) : -14.32290 REMARK 3 B33 (A**2) : 1.87730 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.250 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.126 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.114 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.120 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.111 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.927 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.919 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4753 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6453 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1601 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 787 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4753 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 599 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4585 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 0.91 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.09 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.38 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8OUU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 26-APR-23. REMARK 100 THE DEPOSITION ID IS D_1292130065. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-SEP-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91589 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DIALS REMARK 200 DATA SCALING SOFTWARE : DIALS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 64902 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.770 REMARK 200 RESOLUTION RANGE LOW (A) : 71.590 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 6.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.77 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.80 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.56 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2 M NA FORMATE, 0.1 M NA ACETATE PH REMARK 280 4.6, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.81300 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 107.38550 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.36900 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 107.38550 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.81300 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 28.36900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1038 REMARK 465 ASP A 1039 REMARK 465 SER A 1040 REMARK 465 ASP A 1041 REMARK 465 ILE A 1042 REMARK 465 SER A 1043 REMARK 465 SER A 1044 REMARK 465 PRO A 1045 REMARK 465 LEU A 1046 REMARK 465 LEU A 1047 REMARK 465 GLN A 1048 REMARK 465 ASN A 1049 REMARK 465 THR A 1050 REMARK 465 VAL A 1051 REMARK 465 HIS A 1052 REMARK 465 ILE A 1053 REMARK 465 ASP A 1054 REMARK 465 LEU A 1055 REMARK 465 SER A 1056 REMARK 465 ALA A 1057 REMARK 465 LEU A 1058 REMARK 465 ASN A 1239 REMARK 465 LYS A 1240 REMARK 465 THR A 1241 REMARK 465 GLY A 1242 REMARK 465 GLY B 1038 REMARK 465 ASP B 1039 REMARK 465 SER B 1040 REMARK 465 ASP B 1041 REMARK 465 ILE B 1042 REMARK 465 SER B 1043 REMARK 465 SER B 1044 REMARK 465 PRO B 1045 REMARK 465 LEU B 1046 REMARK 465 LEU B 1047 REMARK 465 GLN B 1048 REMARK 465 ASN B 1049 REMARK 465 THR B 1050 REMARK 465 VAL B 1051 REMARK 465 HIS B 1052 REMARK 465 ILE B 1053 REMARK 465 ASP B 1054 REMARK 465 LEU B 1055 REMARK 465 SER B 1056 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A1086 CG CD NE CZ NH1 NH2 REMARK 470 LYS A1103 CG CD CE NZ REMARK 470 GLU A1172 CG CD OE1 OE2 REMARK 470 LYS A1215 CE NZ REMARK 470 LYS A1232 CG CD CE NZ REMARK 470 LYS A1244 CG CD CE NZ REMARK 470 LYS A1259 CD CE NZ REMARK 470 LYS B1103 CG CD CE NZ REMARK 470 LYS B1161 CE NZ REMARK 470 GLU B1172 CG CD OE1 OE2 REMARK 470 ASN B1175 CG OD1 ND2 REMARK 470 LYS B1199 CE NZ REMARK 470 LYS B1215 CD CE NZ REMARK 470 LYS B1244 CD CE NZ REMARK 470 LYS B1259 CG CD CE NZ REMARK 470 LYS B1318 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A1075 -13.37 -142.44 REMARK 500 THR A1116 -42.66 -132.49 REMARK 500 ARG A1203 -17.82 76.40 REMARK 500 GLN A1298 3.54 -69.57 REMARK 500 THR B1116 -53.81 -128.52 REMARK 500 SER B1135 88.65 -152.62 REMARK 500 ARG B1203 -16.23 73.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1730 DISTANCE = 5.86 ANGSTROMS REMARK 525 HOH A1731 DISTANCE = 5.87 ANGSTROMS REMARK 525 HOH A1732 DISTANCE = 6.65 ANGSTROMS REMARK 525 HOH A1733 DISTANCE = 7.03 ANGSTROMS DBREF 8OUU A 1038 1346 UNP P08581 MET_HUMAN 1038 1346 DBREF 8OUU B 1038 1346 UNP P08581 MET_HUMAN 1038 1346 SEQADV 8OUU VAL A 1228 UNP P08581 ASP 1228 ENGINEERED MUTATION SEQADV 8OUU VAL B 1228 UNP P08581 ASP 1228 ENGINEERED MUTATION SEQRES 1 A 309 GLY ASP SER ASP ILE SER SER PRO LEU LEU GLN ASN THR SEQRES 2 A 309 VAL HIS ILE ASP LEU SER ALA LEU ASN PRO GLU LEU VAL SEQRES 3 A 309 GLN ALA VAL GLN HIS VAL VAL ILE GLY PRO SER SER LEU SEQRES 4 A 309 ILE VAL HIS PHE ASN GLU VAL ILE GLY ARG GLY HIS PHE SEQRES 5 A 309 GLY CYS VAL TYR HIS GLY THR LEU LEU ASP ASN ASP GLY SEQRES 6 A 309 LYS LYS ILE HIS CYS ALA VAL LYS SER LEU ASN ARG ILE SEQRES 7 A 309 THR ASP ILE GLY GLU VAL SER GLN PHE LEU THR GLU GLY SEQRES 8 A 309 ILE ILE MET LYS ASP PHE SER HIS PRO ASN VAL LEU SER SEQRES 9 A 309 LEU LEU GLY ILE CYS LEU ARG SER GLU GLY SER PRO LEU SEQRES 10 A 309 VAL VAL LEU PRO TYR MET LYS HIS GLY ASP LEU ARG ASN SEQRES 11 A 309 PHE ILE ARG ASN GLU THR HIS ASN PRO THR VAL LYS ASP SEQRES 12 A 309 LEU ILE GLY PHE GLY LEU GLN VAL ALA LYS GLY MET LYS SEQRES 13 A 309 TYR LEU ALA SER LYS LYS PHE VAL HIS ARG ASP LEU ALA SEQRES 14 A 309 ALA ARG ASN CYS MET LEU ASP GLU LYS PHE THR VAL LYS SEQRES 15 A 309 VAL ALA ASP PHE GLY LEU ALA ARG VAL MET TYR ASP LYS SEQRES 16 A 309 GLU TYR TYR SER VAL HIS ASN LYS THR GLY ALA LYS LEU SEQRES 17 A 309 PRO VAL LYS TRP MET ALA LEU GLU SER LEU GLN THR GLN SEQRES 18 A 309 LYS PHE THR THR LYS SER ASP VAL TRP SER PHE GLY VAL SEQRES 19 A 309 LEU LEU TRP GLU LEU MET THR ARG GLY ALA PRO PRO TYR SEQRES 20 A 309 PRO ASP VAL ASN THR PHE ASP ILE THR VAL TYR LEU LEU SEQRES 21 A 309 GLN GLY ARG ARG LEU LEU GLN PRO GLU TYR CYS PRO ASP SEQRES 22 A 309 PRO LEU TYR GLU VAL MET LEU LYS CYS TRP HIS PRO LYS SEQRES 23 A 309 ALA GLU MET ARG PRO SER PHE SER GLU LEU VAL SER ARG SEQRES 24 A 309 ILE SER ALA ILE PHE SER THR PHE ILE GLY SEQRES 1 B 309 GLY ASP SER ASP ILE SER SER PRO LEU LEU GLN ASN THR SEQRES 2 B 309 VAL HIS ILE ASP LEU SER ALA LEU ASN PRO GLU LEU VAL SEQRES 3 B 309 GLN ALA VAL GLN HIS VAL VAL ILE GLY PRO SER SER LEU SEQRES 4 B 309 ILE VAL HIS PHE ASN GLU VAL ILE GLY ARG GLY HIS PHE SEQRES 5 B 309 GLY CYS VAL TYR HIS GLY THR LEU LEU ASP ASN ASP GLY SEQRES 6 B 309 LYS LYS ILE HIS CYS ALA VAL LYS SER LEU ASN ARG ILE SEQRES 7 B 309 THR ASP ILE GLY GLU VAL SER GLN PHE LEU THR GLU GLY SEQRES 8 B 309 ILE ILE MET LYS ASP PHE SER HIS PRO ASN VAL LEU SER SEQRES 9 B 309 LEU LEU GLY ILE CYS LEU ARG SER GLU GLY SER PRO LEU SEQRES 10 B 309 VAL VAL LEU PRO TYR MET LYS HIS GLY ASP LEU ARG ASN SEQRES 11 B 309 PHE ILE ARG ASN GLU THR HIS ASN PRO THR VAL LYS ASP SEQRES 12 B 309 LEU ILE GLY PHE GLY LEU GLN VAL ALA LYS GLY MET LYS SEQRES 13 B 309 TYR LEU ALA SER LYS LYS PHE VAL HIS ARG ASP LEU ALA SEQRES 14 B 309 ALA ARG ASN CYS MET LEU ASP GLU LYS PHE THR VAL LYS SEQRES 15 B 309 VAL ALA ASP PHE GLY LEU ALA ARG VAL MET TYR ASP LYS SEQRES 16 B 309 GLU TYR TYR SER VAL HIS ASN LYS THR GLY ALA LYS LEU SEQRES 17 B 309 PRO VAL LYS TRP MET ALA LEU GLU SER LEU GLN THR GLN SEQRES 18 B 309 LYS PHE THR THR LYS SER ASP VAL TRP SER PHE GLY VAL SEQRES 19 B 309 LEU LEU TRP GLU LEU MET THR ARG GLY ALA PRO PRO TYR SEQRES 20 B 309 PRO ASP VAL ASN THR PHE ASP ILE THR VAL TYR LEU LEU SEQRES 21 B 309 GLN GLY ARG ARG LEU LEU GLN PRO GLU TYR CYS PRO ASP SEQRES 22 B 309 PRO LEU TYR GLU VAL MET LEU LYS CYS TRP HIS PRO LYS SEQRES 23 B 309 ALA GLU MET ARG PRO SER PHE SER GLU LEU VAL SER ARG SEQRES 24 B 309 ILE SER ALA ILE PHE SER THR PHE ILE GLY HET GOL A1401 6 HET EDO A1402 4 HET FMT A1403 3 HET W49 A1404 28 HET EDO B1401 4 HET EDO B1402 4 HET FMT B1403 3 HET FMT B1404 3 HET W49 B1405 28 HETNAM GOL GLYCEROL HETNAM EDO 1,2-ETHANEDIOL HETNAM FMT FORMIC ACID HETNAM W49 5-(3-ETHYNYL-5-FLUORANYL-1H-INDAZOL-7-YL)-1-[(1S)-1- HETNAM 2 W49 PHENYLETHYL]PYRIMIDINE-2,4-DIONE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 3 GOL C3 H8 O3 FORMUL 4 EDO 3(C2 H6 O2) FORMUL 5 FMT 3(C H2 O2) FORMUL 6 W49 2(C21 H15 F N4 O2) FORMUL 12 HOH *431(H2 O) HELIX 1 AA1 ASN A 1059 GLN A 1067 1 9 HELIX 2 AA2 HIS A 1068 VAL A 1070 5 3 HELIX 3 AA3 ASP A 1117 ASP A 1133 1 17 HELIX 4 AA4 ASP A 1164 ASN A 1171 1 8 HELIX 5 AA5 THR A 1177 LYS A 1198 1 22 HELIX 6 AA6 ALA A 1206 ARG A 1208 5 3 HELIX 7 AA7 TYR A 1230 HIS A 1238 1 9 HELIX 8 AA8 PRO A 1246 MET A 1250 5 5 HELIX 9 AA9 ALA A 1251 GLN A 1258 1 8 HELIX 10 AB1 THR A 1261 THR A 1278 1 18 HELIX 11 AB2 ASN A 1288 PHE A 1290 5 3 HELIX 12 AB3 ASP A 1291 GLN A 1298 1 8 HELIX 13 AB4 PRO A 1309 TRP A 1320 1 12 HELIX 14 AB5 LYS A 1323 ARG A 1327 5 5 HELIX 15 AB6 SER A 1329 THR A 1343 1 15 HELIX 16 AB7 ASN B 1059 GLN B 1067 1 9 HELIX 17 AB8 HIS B 1068 VAL B 1070 5 3 HELIX 18 AB9 ASP B 1117 ASP B 1133 1 17 HELIX 19 AC1 ASP B 1164 ASN B 1171 1 8 HELIX 20 AC2 THR B 1177 LYS B 1198 1 22 HELIX 21 AC3 ALA B 1206 ARG B 1208 5 3 HELIX 22 AC4 TYR B 1230 GLY B 1242 1 13 HELIX 23 AC5 PRO B 1246 MET B 1250 5 5 HELIX 24 AC6 ALA B 1251 THR B 1257 1 7 HELIX 25 AC7 THR B 1261 THR B 1278 1 18 HELIX 26 AC8 ASN B 1288 PHE B 1290 5 3 HELIX 27 AC9 ASP B 1291 GLN B 1298 1 8 HELIX 28 AD1 PRO B 1309 TRP B 1320 1 12 HELIX 29 AD2 LYS B 1323 ARG B 1327 5 5 HELIX 30 AD3 SER B 1329 THR B 1343 1 15 SHEET 1 AA1 5 LEU A1076 GLY A1087 0 SHEET 2 AA1 5 GLY A1090 LEU A1098 -1 O GLY A1090 N GLY A1087 SHEET 3 AA1 5 LYS A1104 SER A1111 -1 O SER A1111 N CYS A1091 SHEET 4 AA1 5 LEU A1154 PRO A1158 -1 O LEU A1157 N ALA A1108 SHEET 5 AA1 5 GLY A1144 CYS A1146 -1 N GLY A1144 O VAL A1156 SHEET 1 AA2 2 CYS A1210 LEU A1212 0 SHEET 2 AA2 2 VAL A1218 VAL A1220 -1 O LYS A1219 N MET A1211 SHEET 1 AA3 5 LEU B1076 GLY B1087 0 SHEET 2 AA3 5 GLY B1090 LEU B1098 -1 O THR B1096 N ILE B1077 SHEET 3 AA3 5 LYS B1104 LEU B1112 -1 O SER B1111 N CYS B1091 SHEET 4 AA3 5 LEU B1154 PRO B1158 -1 O LEU B1157 N ALA B1108 SHEET 5 AA3 5 GLY B1144 CYS B1146 -1 N GLY B1144 O VAL B1156 SHEET 1 AA4 2 CYS B1210 LEU B1212 0 SHEET 2 AA4 2 VAL B1218 VAL B1220 -1 O LYS B1219 N MET B1211 CRYST1 53.626 56.738 214.771 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018648 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017625 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004656 0.00000